Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Chymase Inhibition Prevents Fibronectin And Myofibrillar Loss And Improves Cardiomyocyte Function And LV Torsion Angle In Dogs With Isolated Mitral Regurgitation
B. Pat, Yuanwen Chen, C. Killingsworth, J. Gladden, K. Shi, Junying Zheng, P. Powell, G. Walcott, M. Ahmed, H. Gupta, Ravi Desai, Chih-Chang Wei, N. Hase, T. Kobayashi, A. Sabri, H. Granzier, T. Denney, M. Tillson, A. Dillon, A. Husain, L. Dell'Italia
Published 2010 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Background— The left ventricular (LV) dilatation of isolated mitral regurgitation (MR) is associated with an increase in chymase and a decrease in interstitial collagen and extracellular matrix. In addition to profibrotic effects, chymase has significant antifibrotic actions because it activates matrix metalloproteinases and kallikrein and degrades fibronectin. Thus, we hypothesize that chymase inhibitor (CI) will attenuate extracellular matrix loss and LV remodeling in MR. Methods and Results— We studied dogs with 4 months of untreated MR (MR; n=9) or MR treated with CI (MR+CI; n=8). Cine MRI demonstrated a >40% increase in LV end-diastolic volume in both groups, consistent with a failure of CI to improve a 25% decrease in interstitial collagen in MR. However, LV cardiomyocyte fractional shortening was decreased in MR versus normal dogs (3.71±0.24% versus 4.81±0.31%; P<0.05) and normalized in MR+CI dogs (4.85±0.44%). MRI with tissue tagging demonstrated an increase in LV torsion angle in MR+CI versus MR dogs. CI normalized the significant decrease in fibronectin and FAK phosphorylation and prevented cardiomyocyte myofibrillar degeneration in MR dogs. In addition, total titin and its stiffer isoform were increased in the LV epicardium and paralleled the changes in fibronectin and FAK phosphorylation in MR+CI dogs. Conclusions— These results suggest that chymase disrupts cell surface–fibronectin connections and FAK phosphorylation that can adversely affect cardiomyocyte myofibrillar structure and function. The greater effect of CI on epicardial versus endocardial titin and noncollagen cell surface proteins may be responsible for the increase in torsion angle in chronic MR.
This paper references
Dog Mast Cell α-Chymase Activates Progelatinase B by Cleaving the Phe88-Gln89 and Phe91-Glu92 Bonds of the Catalytic Domain*
K. Fang (1997)
Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction >60%.
M. Ahmed (2010)
Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control.
Y. Nagatomo (2000)
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs.
L. Dell'Italia (1997)
Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog.
J. A. Stewart (2003)
Left ventricular torsion
IK Russel (2009)
Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving 1494 Circulation October 12, 2010 fibronectin degradation and disruption of focal adhesions
MJ Leskinen (2003)
Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide.
N. Kim (1999)
Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation.
B. Pat (2008)
Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation.
H. Tsutsui (1994)
Sympathetic Activation Causes Focal Adhesion Signaling Alteration in Early Compensated Volume Overload Attributable to Isolated Mitral Regurgitation in the Dog
A. Sabri (2008)
Upregulation of cardiac interstitial chymase after canine myocardial ischemia and reperfusion
Chih-Chang Wei (2008)
Titin-based mechanical signalling in normal and failing myocardium.
M. Krüger (2009)
Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging
N. Osman (1999)
Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation
H. Oral (2003)
Human chymase degrades human fibronectin.
K. Okumura (2004)
Bronchial tissue kallikrein activity is regulated by hyaluronic acid binding.
R. Forteza (1999)
Vertical agarose gel electrophoresis and electroblotting of high‐molecular‐weight proteins
C. M. Warren (2003)
Independent effects of preload, afterload, and contractility on left ventricular torsion.
S. Dong (1999)
Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice.
X. Peng (2006)
A dual propagation contours technique for semi-automated assessment of systolic and diastolic cardiac function by CMR
W. Feng (2009)
Alterations in the determinants of diastolic suction during pacing tachycardia.
S. Bell (2000)
Mast Cell Chymase Induces Smooth Muscle Cell Apoptosis by a Mechanism Involving Fibronectin Degradation and Disruption of Focal Adhesions
M. Leskinen (2003)
Microarray Identifies Extensive Downregulation of Noncollagen Extracellular Matrix and Profibrotic Growth Factor Genes in Chronic Isolated Mitral Regurgitation in the Dog
Junying Zheng (2009)
Vertical agarose gel
A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2*
E. Tchougounova (2005)
Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload.
J. Samuel (1991)
The Overall Pattern of Cardiac Contraction Depends on a Spatial Gradient of Myosin Regulatory Light Chain Phosphorylation
J. Davis (2001)
Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.
H. Urata (1990)
Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation.
L. Dell'Italia (1995)
Kallikrein gene ‘knock-down’ by small interfering RNA transfection induces a profibrotic phenotype in rat mesangial cells
I. Pawluczyk (2008)
Titin isoform expression in aortic stenosis.
L. Williams (2009)
Physiological functions of the giant elastic protein titin in mammalian striated muscle.
Norio Fukuda (2008)
Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog.
G. Perry (2002)
Titin isoform expression in normal and hypertensive myocardium.
C. M. Warren (2003)
Left ventricular torsion: an expanding role in the analysis of myocardial dysfunction.
I. Rüssel (2009)
Transmural gradients of cardiac myofiber shortening in aortic valve stenosis patients using MRI tagging.
A. van der Toorn (2002)
This paper is referenced by
A graph theoretic approach for computing 3D+time biventricular cardiac strain from tagged MRI data
Ming Li (2017)
Implications of protease activation in cardiac dysfunction and development of genetic cardiomyopathy in hamsters.
A. Müller (2012)
Chymase uptake by cardiomyocytes results in myosin degradation in cardiac volume overload
P. Powell (2019)
Reduced Left Atrial Emptying Fraction and Chymase Activation in Pathophysiology of Primary Mitral Regurgitation
Brittany Butts (2020)
Chymase mediates angiotensin-(1-12) metabolism in normal human hearts.
S. Ahmad (2013)
N. Dhalla (2013)
Secretomic Analysis Identifies Alpha-1 Antitrypsin (A1AT) as a Required Protein in Cancer Cell Migration, Invasion, and Pericellular Fibronectin Assembly for Facilitating Lung Colonization of Lung Adenocarcinoma Cells*
Ying-Hua Chang (2012)
Oxidative stress and myocardial remodeling in chronic mitral regurgitation.
J. Gladden (2011)
Development of an acellular annuloplasty ring for atrioventricular valve repair
Mark Thomas Hepples (2015)
Angiotensin-(1-12): A Chymase-Mediated Cellular Angiotensin II Substrate
S. Ahmad (2014)
Translational success stories: angiotensin receptor 1 antagonists in heart failure.
L. Dell'Italia (2011)
Blunting of estrogen modulation of cardiac cellular chymase/RAS activity and function in SHR
S. Ahmad (2018)
Cardiac extracellular matrix tenascin-C deposition during fibronectin degradation.
Shuangtao Ma (2011)
Dual inhibition of cathepsin G and chymase reduces myocyte death and improves cardiac remodeling after myocardial ischemia reperfusion injury
Bahman Hooshdaran (2017)
Mitral Annular Dynamics in Myxomatous Valve Disease: New Insights With Real-Time 3-Dimensional Echocardiography
J. Grewal (2010)
The multiple mechanistic faces of a pure volume overload: implications for therapy.
J. Barnes (2014)
Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.
L. Dell'Italia (2018)
Role of inflammation and extracellular matrix remodelling in dogs with cardiac and systemic diseases
Sonja Fonfara (2013)
Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease.
Melanie J. Hezzell (2014)
Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial Infarction
M. Houde (2018)
Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy
B. Jugdutt (2014)
Motion Estimation from Tagged MR Images and Application to Cardiac Strain Evaluation and Functional Analysis of Ocular Tissues
Ming Li (2015)
Chapter 590 – Chymases
G. Caughey (2013)
Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism.
N. Moniwa (2013)
Pharmacologic management of myxomatous mitral valve disease in dogs.
C. Atkins (2012)
Mast cell proteases as pharmacological targets.
G. Caughey (2016)
Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload.
L. Fu (2016)
Improvement of cardiovascular remodelling by chymase inhibitor
S. Takai (2016)
Extended Cleavage Specificities of Rabbit and Guinea Pig Mast Cell Chymases: Two Highly Specific Leu-Ases
Yuan Zhongwei (2019)
Implication du cytosquelette dans les dysfonctions myocardiques : exemple de la cardiomyopathie septique
S. Preau (2013)
Suppression of Conjunctival Scarring by Chymase Inhibitor in a Canine Symblepharon Model
K. Tajiri (2016)
Proteases as Clinical Markers of Adverse Remodeling for Heart Failure in the Aging Population
B. Jugdutt (2014)See more